Identification of adjuvants in plant protection products applying a suspect screening workflow based on orthogonal techniques.

Anal Bioanal Chem

Research Group "Analytical Chemistry of Contaminants", Department of Chemistry and Physics, Research Centre for Mediterranean Intensive Agrosystems and Agri-Food Biotechnology (CIAIMBITAL), University of Almeria, Agrifood Campus of International Excellence, ceiA3, 04120, Almeria, Spain.

Published: July 2020

In this study, the identification of adjuvants (surfactants and solvents) in quizalofop-p-ethyl plant protection products (PPPs) was carried out by applying nuclear magnetic resonance (NMR), ultra-high-performance liquid chromatography (UHPLC) and gas chromatography (GC), both coupled to high-resolution mass spectrometry (HRMS), and using a suspect analysis approach. NMR provided a rapid and global overview of the composition of the studied samples and supported the tentative identification of the glycol ether family, commonly employed as surfactants, and 2-ethyl-1-butanol. UHPLC-HRMS was used for characterization of the glycol polymer surfactants, while GC-HRMS was used to obtain information about volatile organic compounds (benzene or naphthalene derivates) present in the PPPs. A total of nine adjuvants were characterized in the tested PPPs, belonging to naphthalene, benzene, sulphate and fatty acid esters of glycerol families. In addition, the estimation of compound concentrations was carried out using GC(LC)-HRMS, and finally, these concentration levels were related to their toxicity values.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00216-020-02662-0DOI Listing

Publication Analysis

Top Keywords

identification adjuvants
8
plant protection
8
protection products
8
adjuvants plant
4
products applying
4
applying suspect
4
suspect screening
4
screening workflow
4
workflow based
4
based orthogonal
4

Similar Publications

Heterologous biosynthesis of saponin adjuvants from : A symbolic achievement in metabolic engineering.

Acta Pharm Sin B

December 2024

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.

View Article and Find Full Text PDF

Thymol and Carvacrol as Potential Tocolytic and Anti-inflammatory Agents in Pregnant Rat Uterus.

Curr Mol Pharmacol

January 2025

Área Académica de Medicina del Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Pachuca, Hidalgo, México.

Introduction: This work aimed to evaluate the anti-inflammatory and myorelaxant effect of thymol (TM) and carvacrol (CAR) in the pregnant rat uterus. Both compounds exhibit considerable antimicrobial, antispasmodic, and anti-inflammatory effects and due to these properties, they were studied in this in vitro model of premature birth induced by infection.

Method: All uterine tissues were studied in uterine contraction tests to determine the inhibitory effect of TM, CAR (10, 56, 100, 150, and 230 μM), and nifedipine (a calcium channel antagonist) on phasic and tonic contraction induced by electro- and pharmacomechanical stimuli.

View Article and Find Full Text PDF

: Cervical mesonephric adenocarcinomas (MNACs) are among the rarest neoplasms of the female genital tract. Unlike the majority of cervical cancers, which are predominantly squamous in origin and strongly associated with HPV seropositivity, MNACs are distinct in both histology and pathophysiology. Despite their unique characteristics, MNACs have historically been managed in parallel with squamous cell carcinomas, resulting in a lack of optimised, evidence-based treatment protocols.

View Article and Find Full Text PDF

Background: Adenoid cystic carcinoma (ACC) is a rare glandular malignancy, commonly originating in salivary glands of the head and neck. Given its protracted growth, ACC is usually diagnosed in advanced stage. Treatment of ACC is limited to surgery and/or adjuvant radiotherapy, which often fails to prevent disease recurrence, and no FDA-approved targeted therapies are currently available.

View Article and Find Full Text PDF

A Bibliometric Analysis on Multi-epitope Vaccine Development Against SARS-CoV-2: Current Status, Development, and Future Directions.

Mol Biotechnol

January 2025

Department of Biological Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, 47500, Petaling Jaya, Selangor, Malaysia.

The etiological agent for the coronavirus disease 2019 (COVID-19), the SARS-CoV-2, caused a global pandemic. Although mRNA, viral-vectored, DNA, and recombinant protein vaccine candidates were effective against the SARS-CoV-2 Wuhan strain, the emergence of SARS-CoV-2 variants of concern (VOCs) reduced the protective efficacies of these vaccines. This necessitates the need for effective and accelerated vaccine development against mutated VOCs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!